PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain.
The Biochemical Journal
Malik, Asad U AU; Karapetsas, Athanasios A; Nirujogi, Raja S RS; Chatterjee, Deep D; Phung, Toan K TK; Wightman, Melanie M; Gourlay, Robert R; Morrice, Nick N; Mathea, Sebastian S; Knapp, Stefan S; Alessi, Dario R DR
Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding.
The Biochemical Journal
Kalogeropulou, Alexia F AF; Purlyte, Elena E; Tonelli, Francesca F; Lange, Sven M SM; Wightman, Melanie M; Prescott, Alan R AR; Padmanabhan, Shalini S; Sammler, Esther E; Alessi, Dario R DR
Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2.
Proceedings Of The National Academy Of Sciences Of The United States Of America
Schmidt, Sven H SH; Weng, Jui-Hung JH; Aoto, Phillip C PC; Boassa, Daniela D; Mathea, Sebastian S; Silletti, Steve S; Hu, Junru J; Wallbott, Maximilian M; Komives, Elizabeth A EA; Knapp, Stefan S; Herberg, Friedrich W FW; Taylor, Susan S SS
Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms.
The Biochemical Journal
Malik, Asad U AU; Karapetsas, Athanasios A; Nirujogi, Raja S RS; Mathea, Sebastian S; Chatterjee, Deep D; Pal, Prosenjit P; Lis, Pawel P; Taylor, Matthew M; Purlyte, Elena E; Gourlay, Robert R; Dorward, Mark M; Weidlich, Simone S; Toth, Rachel R; Polinski, Nicole K NK; Knapp, Stefan S; Tonelli, Francesca F; Alessi, Dario R DR
The dynamic switch mechanism that leads to activation of LRRK2 is embedded in the DFGψ motif in the kinase domain.
Proceedings Of The National Academy Of Sciences Of The United States Of America
Schmidt, Sven H SH; Knape, Matthias J MJ; Boassa, Daniela D; Mumdey, Natascha N; Kornev, Alexandr P AP; Ellisman, Mark H MH; Taylor, Susan S SS; Herberg, Friedrich W FW
Rab29 activation of the Parkinson's disease-associated LRRK2 kinase.
The Embo Journal
Purlyte, Elena E; Dhekne, Herschel S HS; Sarhan, Adil R AR; Gomez, Rachel R; Lis, Pawel P; Wightman, Melanie M; Martinez, Terina N TN; Tonelli, Francesca F; Pfeffer, Suzanne R SR; Alessi, Dario R DR
Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis.
Elife
Steger, Martin M; Diez, Federico F; Dhekne, Herschel S HS; Lis, Pawel P; Nirujogi, Raja S RS; Karayel, Ozge O; Tonelli, Francesca F; Martinez, Terina N TN; Lorentzen, Esben E; Pfeffer, Suzanne R SR; Alessi, Dario R DR; Mann, Matthias M
Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling.
Molecular Neurodegeneration
Berwick, Daniel C DC; Javaheri, Behzad B; Wetzel, Andrea A; Hopkinson, Mark M; Nixon-Abell, Jonathon J; Grannò, Simone S; Pitsillides, Andrew A AA; Harvey, Kirsten K
Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors.
The Biochemical Journal
Ito, Genta G; Katsemonova, Kristina K; Tonelli, Francesca F; Lis, Pawel P; Baptista, Marco A S MA; Shpiro, Natalia N; Duddy, Graham G; Wilson, Steve S; Ho, Philip Wing-Lok PW; Ho, Shu-Leong SL; Reith, Alastair D AD; Alessi, Dario R DR
Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation.
The Journal Of Neuroscience : The Official Journal Of The Society For Neuroscience
Matikainen-Ankney, Bridget A BA; Kezunovic, Nebojsa N; Mesias, Roxana E RE; Tian, Yuan Y; Williams, Frances M FM; Huntley, George W GW; Benson, Deanna L DL
Arsenite stress down-regulates phosphorylation and 14-3-3 binding of leucine-rich repeat kinase 2 (LRRK2), promoting self-association and cellular redistribution.
The Journal Of Biological Chemistry
Mamais, Adamantios A; Chia, Ruth R; Beilina, Alexandra A; Hauser, David N DN; Hall, Christine C; Lewis, Patrick A PA; Cookson, Mark R MR; Bandopadhyay, Rina R
In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2.
Frontiers In Molecular Neuroscience
Vancraenenbroeck, Renée R; De Raeymaecker, Joren J; Lobbestael, Evy E; Gao, Fangye F; De Maeyer, Marc M; Voet, Arnout A; Baekelandt, Veerle V; Taymans, Jean-Marc JM
PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65.
Open Biology
Kondapalli, Chandana C; Kazlauskaite, Agne A; Zhang, Ning N; Woodroof, Helen I HI; Campbell, David G DG; Gourlay, Robert R; Burchell, Lynn L; Walden, Helen H; Macartney, Thomas J TJ; Deak, Maria M; Knebel, Axel A; Alessi, Dario R DR; Muqit, Miratul M K MM
The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation.
The Biochemical Journal
Rudenko, Iakov N IN; Kaganovich, Alice A; Hauser, David N DN; Beylina, Aleksandra A; Chia, Ruth R; Ding, Jinhui J; Maric, Dragan D; Jaffe, Howard H; Cookson, Mark R MR
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization.
The Biochemical Journal
Dzamko, Nicolas N; Deak, Maria M; Hentati, Faycal F; Reith, Alastair D AD; Prescott, Alan R AR; Alessi, Dario R DR; Nichols, R Jeremy RJ
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease.
The Biochemical Journal
Nichols, R Jeremy RJ; Dzamko, Nicolas N; Hutti, Jessica E JE; Cantley, Lewis C LC; Deak, Maria M; Moran, Jennifer J; Bamborough, Paul P; Reith, Alastair D AD; Alessi, Dario R DR